UTI Drug Recalled

Sandoz Inc. is pulling 14,366 bottles of 100-mg nitrofurantoin capsules, USP (monohydrate/macrocrystals), because of cross-contamination with other products, according to the November 21, 2018, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 100-capsule bottles (NDC 0185-0122-01) from lots JB4952 and JA7322 (Exp. 3/20) and 1000-capsule bottles (NDC 0185-0122-10) from lot JA7324 (Exp. 3/20). Capsules affected by the recall were distributed by Sandoz throughout the United States.

Sandoz voluntarily initiated the recall November 2, 2018. On November 20, 2018, the FDA designated it Class III. According to the classification, use of the recalled capsules is not likely to cause adverse health consequences.

Nitrofurantoin is a prescription antibiotic used to treat urinary tract infections caused by certain bacteria.

—Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here